SCHEMBL14546006

SCHEMBL14546006

CCc1ccc(S(=O)(=O)NCc2ccc(CNc3cc(-c4ccccc4Cl)nc4c(C)cnn34)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 8/20 0.54
▸ GSK3B P49841 6/20 0.49
▸ POLB P06746 2/20 0.41
▸ CCNA2 P20248 1/20 0.41
▸ CCNA1 P78396 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ GPR39 O43194 1/20 0.39
▸ CCNE1 P24864 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13120681 0.91 CDK2 (0.67) CDK2GSK3BCCNA2CCNA1CCNE1
SCHEMBL13289053 0.91 CDK2 (0.53) CDK2GSK3BPOLBCCNA2CCNA1
SCHEMBL13120634 0.87 CDK2 (0.62) CDK2GSK3BCCNA2CCNA1CCNE1
SCHEMBL13120668 0.86 CDK2 (0.67) CDK2GSK3BCCNA2CCNA1CYP1A2
SCHEMBL13289052 0.86 CDK2 (0.53) CDK2GSK3BPOLBCCNA2CCNA1
SCHEMBL13120687 0.84 CDK2 (0.69) CDK2GSK3BPOLBCCNA2CCNA1
SCHEMBL14545999 0.83 CDK2 (0.54) CDK2GSK3BPOLBCCNA2CCNA1
SCHEMBL13120696 0.83 CDK2 (0.65) CDK2GSK3BCCNA2CCNA1CCNE1
SCHEMBL13120719 0.83 CDK2 (0.65) CDK2GSK3BCCNA2CCNA1CCNE1
SCHEMBL13120674 0.82 CDK2 (0.67) CDK2GSK3BCCNA2CCNA1GPR39

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback